313 related articles for article (PubMed ID: 26271288)
1. β-Asarone Mitigates Amyloidosis and Downregulates RAGE in a Transgenic Mouse Model of Alzheimer's Disease.
Yang C; Li X; Mo Y; Liu S; Zhao L; Ma X; Fang Z; Chen J; Chen Y; Yu X; Fang S; Zhang Y; Xian S; Wang Q
Cell Mol Neurobiol; 2016 Jan; 36(1):121-30. PubMed ID: 26271288
[TBL] [Abstract][Full Text] [Related]
2. β-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1 transgenic mice by regulating Beclin-1-dependent autophagy.
Deng M; Huang L; Ning B; Wang N; Zhang Q; Zhu C; Fang Y
Brain Res; 2016 Dec; 1652():188-194. PubMed ID: 27737765
[TBL] [Abstract][Full Text] [Related]
3. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
[TBL] [Abstract][Full Text] [Related]
4. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes.
Jiang H; Niu F; Zheng Y; Xu Y
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684
[TBL] [Abstract][Full Text] [Related]
5. Dl-3-n-butylphthalide promotes microglial phagocytosis and inhibits microglial inflammation via regulating AGE-RAGE pathway in APP/PS1 mice.
Lu J; Zhang J; Wang X; Yuan F; Xin B; Li J; Yang Q; Li X; Zhang J; Wang X; Fu J; Guo C
Brain Res Bull; 2024 Jun; 212():110969. PubMed ID: 38705540
[TBL] [Abstract][Full Text] [Related]
6. Alpha-asarone Improves Cognitive Function of APP/PS1 Mice and Reducing Aβ
Zeng L; Zhang D; Liu Q; Zhang J; Mu K; Gao X; Zhang K; Li H; Wang Q; Zheng Y; Mao S
Neuroscience; 2021 Mar; 458():141-152. PubMed ID: 33412244
[TBL] [Abstract][Full Text] [Related]
7. β-Asarone improves learning and memory in Aβ
Han Y; Wang N; Kang J; Fang Y
Metab Brain Dis; 2020 Oct; 35(7):1109-1117. PubMed ID: 32556928
[TBL] [Abstract][Full Text] [Related]
8. The effects of Danggui-Shaoyao-San on neuronal degeneration and amyloidosis in mouse and its molecular mechanism for the treatment of Alzheimer's disease.
Yang C; Mo YS; Chen HF; Huang YH; Li SL; Wang H; Huang SQ; Chang X; Du Q; Wang Q
J Integr Neurosci; 2021 Jun; 20(2):255-264. PubMed ID: 34258924
[TBL] [Abstract][Full Text] [Related]
9. 27-hydroxycholesterol promotes Aβ accumulation via altering Aβ metabolism in mild cognitive impairment patients and APP/PS1 mice.
Zhang X; Xi Y; Yu H; An Y; Wang Y; Tao L; Wang Y; Liu W; Wang T; Xiao R
Brain Pathol; 2019 Jul; 29(4):558-573. PubMed ID: 30582229
[TBL] [Abstract][Full Text] [Related]
10. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of β-asarone against Alzheimer's disease: regulation of synaptic plasticity by increased expression of SYP and GluR1.
Liu SJ; Yang C; Zhang Y; Su RY; Chen JL; Jiao MM; Chen HF; Zheng N; Luo S; Chen YB; Quan SJ; Wang Q
Drug Des Devel Ther; 2016; 10():1461-9. PubMed ID: 27143853
[TBL] [Abstract][Full Text] [Related]
12. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
[TBL] [Abstract][Full Text] [Related]
14. RP1, a RAGE antagonist peptide, can improve memory impairment and reduce Aβ plaque load in the APP/PS1 mouse model of Alzheimer's disease.
Huang YY; Fang N; Luo HR; Gao F; Zou Y; Zhou LL; Zeng QP; Fang SS; Xiao F; Zheng Q
Neuropharmacology; 2020 Dec; 180():108304. PubMed ID: 32931813
[TBL] [Abstract][Full Text] [Related]
15. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
[TBL] [Abstract][Full Text] [Related]
16. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
[TBL] [Abstract][Full Text] [Related]
17. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
18. β-Asarone inhibits neuronal apoptosis via the CaMKII/CREB/Bcl-2 signaling pathway in an in vitro model and AβPP/PS1 mice.
Wei G; Chen YB; Chen DF; Lai XP; Liu DH; Deng RD; Zhou JH; Zhang SX; Li YW; Lii H; Liu LF; Wang Q; Nie H
J Alzheimers Dis; 2013; 33(3):863-80. PubMed ID: 23064259
[TBL] [Abstract][Full Text] [Related]
19. Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease.
Wang CY; Xie JW; Xu Y; Wang T; Cai JH; Wang X; Zhao BL; An L; Wang ZY
Antioxid Redox Signal; 2013 Dec; 19(17):2024-39. PubMed ID: 23541064
[TBL] [Abstract][Full Text] [Related]
20. β‑asarone modulates Beclin‑1, LC3 and p62 expression to attenuate Aβ40 and Aβ42 levels in APP/PS1 transgenic mice with Alzheimer's disease.
Deng M; Huang L; Zhong X
Mol Med Rep; 2020 May; 21(5):2095-2102. PubMed ID: 32186763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
